Scalp Nerve Block on Emergence Agitation

NCT02428283 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Agitation

Interventions

DRUG: Ropivacaine
DRUG: Remifentanil
DRUG: Sevoflurane

Sponsor

Ajou University School of Medicine